These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19745239)

  • 1. Application of the Apriori algorithm for adverse drug reaction detection.
    Kuo MH; Kushniruk AW; Borycki EM; Greig D
    Stud Health Technol Inform; 2009; 148():95-101. PubMed ID: 19745239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential causal association mining algorithm for screening adverse drug reactions in postmarketing surveillance.
    Ji Y; Ying H; Dews P; Mansour A; Tran J; Miller RE; Massanari RM
    IEEE Trans Inf Technol Biomed; 2011 May; 15(3):428-37. PubMed ID: 21435986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of adverse drug events detection: data aggregation and data mining.
    Chazard E; Ficheur G; Merlin B; Genin M; Preda C; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():75-84. PubMed ID: 19745237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward].
    Tribiño G; Maldonado C; Segura O; Díaz J
    Biomedica; 2006 Mar; 26(1):31-41. PubMed ID: 16929901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EU-ADR project: preliminary results and perspective.
    Trifiro G; Fourrier-Reglat A; Sturkenboom MC; Díaz Acedo C; Van Der Lei J;
    Stud Health Technol Inform; 2009; 148():43-9. PubMed ID: 19745234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of adverse drug events: proposal of a data model.
    Chazard E; Merlin B; Ficheur G; Sarfati JC; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():63-74. PubMed ID: 19745236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data mining to generate adverse drug events detection rules.
    Chazard E; Ficheur G; Bernonville S; Luyckx M; Beuscart R
    IEEE Trans Inf Technol Biomed; 2011 Nov; 15(6):823-30. PubMed ID: 21859604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expert explorer: a tool for hospital data visualization and adverse drug event rules validation.
    Băceanu A; Atasiei I; Chazard E; Leroy N;
    Stud Health Technol Inform; 2009; 148():85-94. PubMed ID: 19745238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the feasibility of data mining techniques for early liver cancer detection.
    Kuo MH; Hung CM; Barnett J; Pinheiro F
    Stud Health Technol Inform; 2012; 180():584-8. PubMed ID: 22874258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions in patients in an Iranian department of internal medicine.
    Pourseyed S; Fattahi F; Pourpak Z; Gholami K; Shariatpanahi SS; Moin A; Kazemnejad A; Moin M
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):104-10. PubMed ID: 19101919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions in hospitalized patients: A critique of a meta-analysis.
    Kvasz M; Allen IE; Gordon MJ; Ro EY; Estok R; Olkin I; Ross SD
    MedGenMed; 2000 Apr; 2(2):E3. PubMed ID: 11104449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic investigation of time windows for adverse event data mining for recently approved drugs.
    Hochberg AM; Hauben M; Pearson RK; O'Hara DJ; Reisinger SJ
    J Clin Pharmacol; 2009 Jun; 49(6):626-33. PubMed ID: 19451402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three algorithms used to evaluate adverse drug reactions.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Jul; 43(7):1709-14. PubMed ID: 3752106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.
    Alexopoulou A; Dourakis SP; Mantzoukis D; Pitsariotis T; Kandyli A; Deutsch M; Archimandritis AJ
    Eur J Intern Med; 2008 Nov; 19(7):505-10. PubMed ID: 19013378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining unexpected temporal associations: applications in detecting adverse drug reactions.
    Jin HW; Chen J; He H; Williams GJ; Kelman C; O'Keefe CM
    IEEE Trans Inf Technol Biomed; 2008 Jul; 12(4):488-500. PubMed ID: 18632329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients.
    Smith KM; Jeske CS; Young B; Hatton J
    Neurosurgery; 2006 Mar; 58(3):426-33; discussion 426-33. PubMed ID: 16528181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARM--an efficient algorithm to mine association rules from spatial data.
    Ding Q; Ding Q; Perrizo W
    IEEE Trans Syst Man Cybern B Cybern; 2008 Dec; 38(6):1513-24. PubMed ID: 19022723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between lithium serum level, mood state, and patient-reported adverse drug reactions during long-term lithium treatment: a naturalistic follow-up study.
    Wilting I; Heerdink ER; Mersch PP; den Boer JA; Egberts AC; Nolen WA
    Bipolar Disord; 2009 Jun; 11(4):434-40. PubMed ID: 19500096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.